Home  /  Resource Library  /  Zanubrutinib monotherapy for patients with treatment naive chronic lymphocytic leukemia and 17p deletion

Zanubrutinib monotherapy for patients with treatment naive chronic lymphocytic leukemia and 17p deletion

Results of a study examining zanubrutinib for the first line treatment of CLL.